The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing eligibility for non-intensive chemotherapy (IC) randomized clinical trials (RCT) in patients (pts) with newly diagnosed (ND) AML from the Connect Myeloid Disease Registry.
 
Harry Paul Erba
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Celgene; Daiichi Sankyo; Glycomimetics; Immunogen; Incyte; Janssen Oncology; Jazz Pharmaceuticals; Kura Oncology; Macrogenics; Novartis; Pfizer; Takeda; Trillium Therapeutics
Speakers' Bureau - Abbvie/Genentech; Agios; Celgene; Incyte; Jazz Pharmaceuticals; Novartis
Research Funding - Abbvie; Abbvie (Inst); Agios (Inst); ALX Oncology (Inst); Amgen (Inst); Daiichi Sankyo (Inst); FORMA Therapeutics (Inst); Gilead/Forty Seven (Inst); Glycomimetics (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Macrogenics (Inst); Novartis (Inst); PTC Therapeutics (Inst)
Other Relationship - Celgene; Glycomimetics
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo
 
Daniel Aaron Pollyea
Consulting or Advisory Role - Abbvie; Agios; Amgen; Aprea Therapeutics; Astellas Pharma; Astellas Pharma; BeiGene; BerGenBio; Bristol-Myers Squibb; Celgene; Foghorn Therapeutics; Forty Seven; Genentech; Gilead Sciences; Glycomimetics; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Karyopharm Therapeutics; Kiadis Pharma; Novartis; Syndax; Syros Pharmaceuticals; Takeda
Research Funding - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Karyopharm Therapeutics (Inst); Teva (Inst)
 
Mikkael A. Sekeres
Consulting or Advisory Role - Celgene; Millennium; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Takeda (Inst)
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb/Celgene; Curis; Genentech; Gilead Sciences; Novartis
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb
Research Funding - Abbvie; Aprea Therapeutics; Astex Pharmaceuticals; Bristol-Myers Squibb; Curis; Genentech; Gilead Sciences; Novartis
 
Karen Seiter
Honoraria - Alexion Pharmaceuticals; Incyte; Novartis
Research Funding - Bristol-Myers Squibb; GlycoMimetics; Incyte; Jazz Pharmaceuticals; Rafael Pharmaceuticals; Sellas Life Sciences; Takeda; Theradex
 
Irene DeGutis
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Pavel Kiselev
Employment - Bristol-Myers Squibb/Celgene/Juno
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene/Juno
 
Ali McBride
Employment - Bristol-Myers Squibb/Celgene
Consulting or Advisory Role - EMD Serono; Pfizer; Sandoz
Speakers' Bureau - Bristol-Myers Squibb; Coherus Biosciences; Incyte
 
Edward Yu
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Gail J. Roboz
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; Astellas Pharma; Astex Pharmaceuticals; Bayer; Bayer; Bristol-Myers Squibb; Celgene; Celltrion; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Janssen; Jasper Therapeutics; Jazz Pharmaceuticals; MedImmune; MEI Pharma; Mesoblast; Novartis; Otsuka; Pfizer; Roche; Sandoz; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); amphivena (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Cellectis (Inst); Cellectis (Inst); CTI (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); MEI Pharma (Inst); Moffitt (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Agios; Amgen; Amphivena; Array BioPharma; Astex Pharmaceuticals; Bayer; Celgene; Celltrion; Clovis Oncology; Eisai; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer; Roche/Genentech; Sandoz; Sunesis Pharmaceuticals